Cell and gene therapy (CGT) products are a class of complex biologics, including gene-modified cell products (such as CAR-T cells) and gene therapy vectors directly used for treatment (such as adeno-associated virus vectors). These products have shown great potential in the treatment of a variety of intractable diseases. Due to their complex production processes and the inherent characteristics, testing for purity and impurities are critical.